Insmed (INSM) Cash & Current Investments (2010 - 2026)

Insmed has reported Cash & Current Investments for 17 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 37.51% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 37.51% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, changed 0.26% from the prior year.
• Cash & Current Investments was $1.2 billion for Q2 2026 at Insmed, down from $1.2 billion in the prior quarter.
• The five-year high for Cash & Current Investments was $1.9 billion in Q2 2025, with the low at $513.3 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 40.35% in 2024, then soared 101.34% in 2025.
• Over 5 years, Cash & Current Investments stood at $1.1 billion in 2022, then slumped by 32.03% to $780.4 million in 2023, then soared by 83.72% to $1.4 billion in 2024, then slipped by 0.26% to $1.4 billion in 2025, then declined by 18.86% to $1.2 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.